Lord, Abbett & Co. LLC Neurocrine Biosciences Inc Transaction History

Lord, Abbett & Co. LLC

  • $30.6 Billion
  • Q2 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 34,443 shares of NBIX stock, worth $4.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,443
Previous 391,244 91.2%
Holding current value
$4.27 Million
Previous $54 Million 91.21%
% of portfolio
0.02%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 07, 2024
SELL
$130.86 - $143.19 $46.7 Million - $51.1 Million
-356,801 Reduced 91.2%
34,443 $4.74 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $46.7 Million - $51.1 Million
-356,801 Reduced 91.2%
34,443 $4.74 Million
Q1 2024

Oct 07, 2024
BUY
$130.4 - $143.74 $44.9 Million - $49.5 Million
344,263 Added 732.77%
391,244 $54 Million
Q1 2024

May 09, 2024
BUY
$130.4 - $143.74 $44.9 Million - $49.5 Million
344,263 Added 732.77%
391,244 $54 Million
Q4 2023

Oct 07, 2024
BUY
$106.07 - $132.76 $4.71 Million - $5.89 Million
44,383 Added 1708.35%
46,981 $6.19 Million
Q4 2023

Feb 12, 2024
BUY
$106.07 - $132.76 $4.98 Million - $6.24 Million
46,981 New
46,981 $6.19 Million
Q4 2022

Oct 07, 2024
SELL
$106.72 - $127.06 $3.4 Million - $4.05 Million
-31,845 Reduced 92.46%
2,598 $311,000
Q4 2022

Feb 10, 2023
BUY
$106.72 - $127.06 $277,258 - $330,101
2,598 New
2,598 $311,000
Q2 2020

Aug 14, 2020
SELL
$85.09 - $130.36 $5.71 Million - $8.76 Million
-67,163 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $1.2 Million - $1.81 Million
-15,943 Reduced 19.18%
67,163 $5.81 Million
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $985,614 - $1.35 Million
-11,355 Reduced 12.02%
83,106 $8.93 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $13,159 - $15,935
157 Added 0.17%
94,461 $8.51 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $2.64 Million - $3.33 Million
36,477 Added 63.08%
94,304 $7.96 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $100,014 - $132,077
1,443 Added 2.56%
57,827 $5.1 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $206,258 - $375,442
-3,019 Reduced 5.08%
56,384 $4.03 Million
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $5.87 Million - $7.48 Million
59,403 New
59,403 $7.3 Million

Others Institutions Holding NBIX

# of Institutions
621
Shares Held
95.7M
Call Options Held
583K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email